MAP7D1 and congestive heart failure: Seventeen patients whose LVEF levels were monitored throughout the clinical trial experienced irreversible congestive heart failure (CHF), thus concluding that the decline in LVEF and CHF was correlated with the MAP7D1 gene being a susceptible gene to DIC and HF.